1 |
Non-amyloid liver involvement in familial Mediterranean fever: A systematic literature review.
61
|
Fraisse T...Ducharme-Benard S
|
32196885 |
2020 |
2 |
Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
61
|
Younossi ZM...Henry L
|
32531342 |
2020 |
3 |
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan.
61
|
Su HJ...Liu CJ
|
32499209 |
2020 |
4 |
Use of Nonvascularized Fascia in Liver Transplantation.
61
|
Justo I...Jimenez-Romero C
|
32204902 |
2020 |
5 |
Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
61
|
Vaz J...Midlov P
|
32245414 |
2020 |
6 |
Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
61
|
Eshraghian A...Malek-Hosseini SA
|
31431413 |
2020 |
7 |
Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis.
61
|
Yaghobi R...Moayedi J
|
30346262 |
2020 |
8 |
Prevalence of Occult HBV Infection in Western Countries.
61
|
Pisaturo M...Coppola N
|
32275083 |
2020 |
9 |
Etiology of cirrhosis in the young.
61
|
Olave MC...Jain D
|
31698008 |
2020 |
10 |
Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!
61
|
Jain M...Rela M
|
32055695 |
2020 |
11 |
Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis.
61
|
Valery PC...Powell EE
|
32096890 |
2020 |
12 |
Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
61
|
Enooku K...Koike K
|
31602526 |
2020 |
13 |
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application.
61
|
Xu Y...Feng Y
|
32477116 |
2020 |
14 |
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
61
|
Baratta F...Del Ben M
|
31392821 |
2019 |
15 |
Acute-on-Chronic Liver Failure: Etiology of Chronic and Acute Precipitating Factors and Their Effect on Mortality.
61
|
Gawande A...Nijhawan S
|
31889750 |
2019 |
16 |
Metastatic cholangiocarcinoma in a patient with undiagnosed Wilson disease.
61
|
Mavilia MG...Forouhar F
|
31167735 |
2019 |
17 |
Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine.
61
|
Nalbantoglu I...Jain D
|
31395291 |
2019 |
18 |
Effects of Share 35 Policy on Liver Transplantation Outcomes for Patients With Nonalcoholic Steatohepatitis.
61
|
Zhang Y...Boktour MR
|
31146627 |
2019 |
19 |
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
61
|
Baratta F...Del Ben M
|
31435171 |
2019 |
20 |
Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?
61
|
Akyuz F...Kaymakoglu S
|
31130469 |
2019 |
21 |
Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients.
61
|
Nilsson E...Prytz H
|
30957910 |
2019 |
22 |
Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
61
|
Alswat KA...Al-Osaimi A
|
31219486 |
2019 |
23 |
NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study.
61
|
Axley P...Singal AK
|
30861321 |
2019 |
24 |
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience.
61
|
Cowell E...Miloh T
|
30676520 |
2019 |
25 |
Outcome of Liver Transplant Patients With Intraoperative-Detected Portal Vein Thrombosis: A Retrospective Cohort Study in Shiraz, Iran.
61
|
Bagheri Lankarani K...Malekhosseini SA
|
30995894 |
2019 |
26 |
The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease.
61
|
Kuloglu Z...National LAL-D Study Group
|
30540705 |
2019 |
27 |
Evaluation of Underlying Liver Disease and Its Severity in Children Referred for Liver Transplant: a Single-Center Report From Nemazee Hospital of Shiraz.
61
|
Dehghani SM...Mardani S
|
30836904 |
2019 |
28 |
Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation.
61
|
Nicolau-Raducu R...Raveh Y
|
30548128 |
2019 |
29 |
Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis.
61
|
Icen YK...Koc M
|
30911266 |
2019 |
30 |
Senescent Hepatocytes in Decompensated Liver Show Reduced UPRMT and Its Key Player, CLPP, Attenuates Senescence In Vitro.
61
|
Sen B...Ramakrishna G
|
30878663 |
2019 |
31 |
Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
61
|
Gravito-Soares M...Tome L
|
31113613 |
2019 |
32 |
Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.
61
|
Ghannam JS...Gemmete JJ
|
30291382 |
2019 |
33 |
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
61
|
Calzadilla-Bertot L...Adams LA
|
30609187 |
2019 |
34 |
Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
61
|
Thuluvath PJ...Savva Y
|
29985186 |
2019 |
35 |
Poor Survival After Retransplantation in NASH Cirrhosis.
61
|
Thuluvath AJ...Savva Y
|
29470354 |
2019 |
36 |
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
61
|
Younossi Z...Goodman Z
|
30144554 |
2018 |
37 |
A decompensated cryptogenic cirrhosis? No, a late liver histiocytosis!
61
|
Ouizeman DJ...Anty R
|
30077466 |
2018 |
38 |
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
61
|
Holmer M...Hagstrom H
|
29630771 |
2018 |
39 |
A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.
61
|
Pinero F...Latin American Liver Research, Education, Awareness Network (LALREAN)
|
29773419 |
2018 |
40 |
NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis.
61
|
Giannini EG...Marabotto E
|
30227919 |
2018 |
41 |
Reply to: "NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis": Cryptogenic cirrhosis should not be equated with NASH cirrhosis based on UNOS data mining and Bayesian 'doctrine of chances'.
61
|
Thuluvath PJ...Savva Y
|
29983203 |
2018 |
42 |
Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in 
Sri Lanka
61
|
Bulathsinhala BKS...Dassanayake A
|
30415518 |
2018 |
43 |
Pernicious anemia associated with cryptogenic cirrhosis: Two case reports and a literature review.
61
|
Yan X...Jin J
|
30278550 |
2018 |
44 |
Non-cirrhotic portal hypertension: an imaging review.
61
|
Rajesh S...Arora A
|
29564495 |
2018 |
45 |
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
61
|
Golabi P...Younossi ZM
|
30075518 |
2018 |
46 |
Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
61
|
Reynolds TM...PATHFINDER Project Collaboration group
|
29358478 |
2018 |
47 |
Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.
61
|
An SS...McEvoy MD
|
29573551 |
2018 |
48 |
Role of Glutathione S Transferase M1 and T1 Gene Polymorphism in Hepatitis B Related Liver Diseases and Cryptogenic Cirrhosis.
61
|
Kapahtia S...Kar P
|
29892180 |
2018 |
49 |
A growing hepatic mass in a cryptogenic cirrhosis patient.
61
|
Song JS...Moon WS
|
29050462 |
2018 |
50 |
Raised plasma levels of H2S and nitrate predict intrapulmonary vascular dilations: A preliminary report in patients with cryptogenic cirrhosis.
61
|
Bera C...Eapen CE
|
29984390 |
2018 |